A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation
Gabriella Chirumbolo(University of Bologna), Mario Arpinati(University of Bologna), Michele Dicataldo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Martina Barone(University of Bologna), Gianluca Storci(Azienda USL di Bologna), Enrico Maffini(Istituto di Ematologia di Bologna), Michèle Cavo(Unknown), Serena De Matteis(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Francesca Bonifazi(University of Bologna), Noemi Laprovitera(Azienda USL di Bologna), Francesco Barbato(Deutsches Konsortium für Translationale Krebsforschung), Barbara Sinigaglia(Azienda USL di Bologna)
Cited by 8
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719